Bleakley Financial Group’s Sotera Health SHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$746K Buy
42,022
+27,662
+193% +$436K 0.01% 722
2026
Q1
$206K Buy
+14,360
New +$238K ﹤0.01% 754
2025
Q1
Sell
-11,135
Closed -$152K 905
2024
Q4
$152K Buy
11,135
+72
+0.7% +$1.04K ﹤0.01% 970
2024
Q3
$185K Buy
11,063
+318
+3% +$4.64K 0.01% 934
2024
Q2
$128K Buy
+10,745
New +$123K ﹤0.01% 938
2023
Q3
Sell
-12,509
Closed -$236K 944
2023
Q2
$236K Buy
12,509
+851
+7% +$13.5K 0.01% 800
2023
Q1
$209K Buy
+11,658
New +$195K 0.01% 814

Other funds holding SHC

Bleakley Financial Group's SHC Position: Q2 2026 in Review

Bleakley Financial Group increased its Sotera Health (SHC) stake by 193% in Q2 2026, buying an estimated $436K and bringing the position to 42,022 shares worth $746K. The position accounts for 0.01% of the portfolio, ranked #722.

Bleakley Financial Group first reported a position in SHC in Q1 2023 and has held it in 7 quarters since. 316 funds tracked by Wall St. Rank hold SHC as of Q2 2026.

  • Bleakley Financial Group held 42,022 shares of Sotera Health worth $746K as of Q2 2026.
  • Bleakley Financial Group bought 27,662 Sotera Health shares in Q2 2026, an estimated $436K.
  • Sotera Health made up 0.01% of Bleakley Financial Group's portfolio in Q2 2026, its #722 holding.
  • Bleakley Financial Group first reported a position in Sotera Health in Q1 2023 and has held it in 7 quarters since.
  • 316 funds tracked by Wall St. Rank held Sotera Health as of Q2 2026.

Based on Bleakley Financial Group's 13F filing for Q2 2026, filed 5 Aug 2026.